ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ABBV AbbVie Inc

159.6218
-7.67 (-4.58%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
AbbVie Inc ABBV NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-7.67 -4.58% 159.6218 18:59:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
167.26 157.65 167.46 159.62 167.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202406:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/4/202406:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/4/202407:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/4/202407:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/4/202407:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/4/202406:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/4/202407:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/4/202407:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/4/202407:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/4/202406:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/3/202406:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/3/202410:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/3/202407:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/3/202407:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22/3/202414:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/3/202407:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/3/202407:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/3/202407:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
05/3/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/3/202407:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/3/202406:00PRNCADragonfly has Received Milestone Payment Following Dosing of..
01/3/202418:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:20EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:06EDGAR2Form 144 - Report of proposed sale of securities
29/2/202416:33EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:04EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
27/2/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202407:00GLOBEHealis Therapeutics' asset CKDB-501A shares Phase III..
27/2/202406:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
26/2/202416:08EDGAR2Form 8-K - Current report
26/2/202405:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:04EDGAR2Form 144 - Report of proposed sale of securities
22/2/202407:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
21/2/202417:00EDGAR2Form 144 - Report of proposed sale of securities
21/2/202407:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/2/202407:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
20/2/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock